Melanotan II 10mg

Melanotan II 10mg

$72.00

Melanotan II (MT-II) is a synthetic analog of the peptide hormone alpha-melanocyte-stimulating hormone (α-MSH), designed to activate multiple melanocortin receptors, including MC1R, MC3R, MC4R, and MC5R. Originally developed for its potential in treating sexual dysfunction and promoting skin tanning, MT-II has gained recognition for its ability to enhance skin pigmentation, stimulate sexual arousal, and suppress appetite. Despite its growing interest, Melanotan II remains unapproved for medical use in most countries and is classified as an unregulated substance.

 

 

4o
Category:

Description

Referenced Citations

  1. Brennan, R., et al. (2017). “Melanotan II: acts at melanocortin receptors MC1R, MC3R, MC4R and MC5R to induce skin tanning and suppress appetite.” Pharmacology & Therapeutics, 177, 56-65. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/28223234/
  2. Langan, E. A., et al. (2010). “Melanotan: a potential new treatment for resistant acne?” British Journal of Dermatology, 163(4), 886-887. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/20854435/
  3. Hadley, M. E., et al. (2006). “Discovery and development of novel melanogenic drugs. Melanotan-I and -II.” Pharmaceutical Biotechnology, 329-360. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/16399414/
  4. Dorr, R. T., et al. (1996). “Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.” Life Sciences, 58(20), 1777-1784. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/8637402/
  5. Nelson, M. E., et al. (2019). “Melanotan II non-selectively masks benign and malignant pigmented skin lesions.” Australasian Journal of Dermatology, 60(4), 315-317. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/31168823/

Related products